AAAAAA

   
Results: 1-14 |
Results: 14
Prevention of cardiovascular disease in Sweden: The Norsjo community intervention programme - Motives, methods and intervention components
Authors: Weinehall, L Hellsten, G Boman, K Hallmans, G
Citation: L. Weinehall et al., Prevention of cardiovascular disease in Sweden: The Norsjo community intervention programme - Motives, methods and intervention components, SCAND J P H, 2001, pp. 13-20
Can a sustainable community intervention reduce the health gap? 10-Year evaluation of a Swedish community intervention program for the prevention of cardiovascular disease
Authors: Weinehall, L Hellsten, G Boman, K Hallmans, G Asplund, K Wall, S
Citation: L. Weinehall et al., Can a sustainable community intervention reduce the health gap? 10-Year evaluation of a Swedish community intervention program for the prevention of cardiovascular disease, SCAND J P H, 2001, pp. 59-68
Low angle estimation: Models, methods, and bounds
Authors: Boman, K Stoica, P
Citation: K. Boman et P. Stoica, Low angle estimation: Models, methods, and bounds, DIGIT SIG P, 11(1), 2001, pp. 35-79
Homozygosity for the C-677 -> T mutation of 5,10-methylenetetrahydrofolatereductase and total plasma homocyst(e)ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden
Authors: Thogersen, AM Nilsson, TK Dahlen, G Jansson, JH Boman, K Huhtasaari, F Hallmans, G
Citation: Am. Thogersen et al., Homozygosity for the C-677 -> T mutation of 5,10-methylenetetrahydrofolatereductase and total plasma homocyst(e)ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden, CORON ART D, 12(2), 2001, pp. 85-90
Increased levels of tPA antigen and tPA/PAI-1 complex in myotonic dystrophy
Authors: Johansson, A Boman, K Cederquist, K Forsberg, H Olsson, T
Citation: A. Johansson et al., Increased levels of tPA antigen and tPA/PAI-1 complex in myotonic dystrophy, J INTERN M, 249(6), 2001, pp. 503-510
Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study
Authors: Devereux, RB Bella, J Boman, K Gerdts, E Nieminen, MS Rokkedal, J Papademetriou, V Wachtell, K Wright, J Paranicas, M Okin, PM Roman, MJ Smith, G Dahlof, B
Citation: Rb. Devereux et al., Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study, BLOOD PRESS, 10(2), 2001, pp. 74-82
Influence of diagnostic criteria on the prevalence of abdominal aortic aneurysm
Authors: Wanhainen, A Bjorck, M Boman, K Rutegard, J Bergqvist, D
Citation: A. Wanhainen et al., Influence of diagnostic criteria on the prevalence of abdominal aortic aneurysm, J VASC SURG, 34(2), 2001, pp. 229-235
What else adds to hypertension in predicting stroke? An incident case-referent study
Authors: Ohgren, B Weinehall, L Stegmayr, B Boman, K Hallmans, G Wall, S
Citation: B. Ohgren et al., What else adds to hypertension in predicting stroke? An incident case-referent study, J INTERN M, 248(6), 2000, pp. 475-482
Long-term coping in childhood cancer survivors: influence of illness, treatment and demographic background factors
Authors: Boman, K Bodegard, G
Citation: K. Boman et G. Bodegard, Long-term coping in childhood cancer survivors: influence of illness, treatment and demographic background factors, ACT PAEDIAT, 89(1), 2000, pp. 105-111
Left ventricular wall stresses and wall stress-mass-heart rate products inhypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study
Authors: Devereux, RB Roman, MJ Palmieri, V Okin, PM Boman, K Gerdts, E Nieminen, MS Papademetriou, V Wachtell, K Dahlof, B
Citation: Rb. Devereux et al., Left ventricular wall stresses and wall stress-mass-heart rate products inhypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study, J HYPERTENS, 18(8), 2000, pp. 1129-1138
Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke
Authors: Johansson, L Jansson, JH Boman, K Nilsson, TK Stegmayr, B Hallmans, G
Citation: L. Johansson et al., Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke, STROKE, 31(1), 2000, pp. 26-32
Cost-effectiveness analysis with defined budget: how to distribute resources for the prevention of cardiovascular disease?
Authors: Lindholm, L Hallgren, CG Boman, K Markgren, K Weinehall, L Ogren, JE
Citation: L. Lindholm et al., Cost-effectiveness analysis with defined budget: how to distribute resources for the prevention of cardiovascular disease?, HEALTH POLI, 48(3), 1999, pp. 155-170
Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase
Authors: Dahmoun, M Boman, K Cajander, S Westin, P Backstrom, T
Citation: M. Dahmoun et al., Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase, J CLIN END, 84(5), 1999, pp. 1737-1743
Long-term results from a phase II study of single agent paclitaxel (Taxol (R)) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience
Authors: Trope, C Hogberg, T Kaern, J Bertelsen, K Bjorkholm, E Boman, K Himmelmann, A Horvath, G Jacobsen, A Kuoppola, T Vartianen, J Lund, B Onsrud, M Puistola, U Salmi, T Scheistroen, M Sandvei, R Simonsen, E Sorbe, B Tholander, B Westberg, R
Citation: C. Trope et al., Long-term results from a phase II study of single agent paclitaxel (Taxol (R)) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience, ANN ONCOL, 9(12), 1998, pp. 1301-1307
Risultati: 1-14 |